Variability in immune response genes and prediction of severe SARS-CoV-2 infection (INMUNGEN-Cov2 project)
Genetic factors may contribute to explain the variable clinical response to SARS-CoV-2 infection. To this end we sequenced the DNA of 392 COVID-19 patients from Spain. Whole Exome Sequencing (WES) was performed at two different sequencing centers. Half of the samples were sequenced at a commercial service, NIMGenetics, whereas the other half were sequenced by the EASI-Genomics consortium. Finally, Variant Call Format (VCF) files for each sample was also obtained.
- Type: Exome Sequencing
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000000094 | Illumina NovaSeq 6000 | 392 |
| Publications | Citations |
|---|---|
|
<i>OAS1</i> and <i>OAS3</i> genetic variants enhance inflammatory responses to SARS-CoV-2.
iScience 28: 2025 113966 |
0 |